Cargando…
Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study
INTRODUCTION: The occurrence of metastasis is a threat to patients with colon cancer (CC), and the liver is the most common metastasis organ. However, the role of the extrahepatic organs in patients with liver metastasis (LM) has not been distinctly demonstrated. Therefore, this research aimed to ex...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280983/ https://www.ncbi.nlm.nih.gov/pubmed/37346071 http://dx.doi.org/10.3389/fonc.2023.1172670 |
_version_ | 1785060919453155328 |
---|---|
author | Bai, Shuheng Chen, Ling Zhu, Guixian Xuan, Wang Hu, Fengyuan Liu, Wanyi Li, Wenyang Lan, Ning Chen, Min Yan, Yanli Li, Rong Yang, Yiping Ren, Juan |
author_facet | Bai, Shuheng Chen, Ling Zhu, Guixian Xuan, Wang Hu, Fengyuan Liu, Wanyi Li, Wenyang Lan, Ning Chen, Min Yan, Yanli Li, Rong Yang, Yiping Ren, Juan |
author_sort | Bai, Shuheng |
collection | PubMed |
description | INTRODUCTION: The occurrence of metastasis is a threat to patients with colon cancer (CC), and the liver is the most common metastasis organ. However, the role of the extrahepatic organs in patients with liver metastasis (LM) has not been distinctly demonstrated. Therefore, this research aimed to explore the prognostic value of extrahepatic metastases (EHMs). METHODS: In this retrospective study, a total of 13,662 colon patients with LM between 2010 and 2015 were selected from the Surveillance, Epidemiology, and End Results database (SEER). Fine and Gray’s analysis and K–M survival analysis were utilized to explore the impacts of the number of sites of EHMs and different sites of EHMs on prognosis. Finally, a prognostic nomogram model based on the number of sites of EHMs was constructed, and a string of validation methods was conducted, including concordance index (C-index), receiver operating characteristic curves (ROC), and decision curve analysis (DCA). RESULTS: Patients without EHMs had better prognoses in cancer-specific survival (CSS) and overall survival (OS) than patients with EHMs (p < 0.001). Varied EHM sites of patients had different characteristics of primary location site, grade, and histology. Cumulative incidence rates for CSS surpassed that for other causes in patients with 0, 1, 2, ≥ 3 EHMs, and the patients with more numbers of sites of EHMs revealed worse prognosis in CSS (p < 0.001). However, patients with different EHM sites had a minor difference in cumulative incidence rates for CSS (p = 0.106). Finally, a nomogram was constructed to predict the survival probability of patients with EHMs, which is based on the number of sites of EHMs and has been proven an excellent predictive ability. CONCLUSION: The number of sites of EHMs was a significant prognostic factor of CC patients with LM. However, the sites of EHMs showed limited impact on survival. Furthermore, a nomogram based on the number of sites of EHMs was constructed to predict the OS of patients with EHMs accurately. |
format | Online Article Text |
id | pubmed-10280983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102809832023-06-21 Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study Bai, Shuheng Chen, Ling Zhu, Guixian Xuan, Wang Hu, Fengyuan Liu, Wanyi Li, Wenyang Lan, Ning Chen, Min Yan, Yanli Li, Rong Yang, Yiping Ren, Juan Front Oncol Oncology INTRODUCTION: The occurrence of metastasis is a threat to patients with colon cancer (CC), and the liver is the most common metastasis organ. However, the role of the extrahepatic organs in patients with liver metastasis (LM) has not been distinctly demonstrated. Therefore, this research aimed to explore the prognostic value of extrahepatic metastases (EHMs). METHODS: In this retrospective study, a total of 13,662 colon patients with LM between 2010 and 2015 were selected from the Surveillance, Epidemiology, and End Results database (SEER). Fine and Gray’s analysis and K–M survival analysis were utilized to explore the impacts of the number of sites of EHMs and different sites of EHMs on prognosis. Finally, a prognostic nomogram model based on the number of sites of EHMs was constructed, and a string of validation methods was conducted, including concordance index (C-index), receiver operating characteristic curves (ROC), and decision curve analysis (DCA). RESULTS: Patients without EHMs had better prognoses in cancer-specific survival (CSS) and overall survival (OS) than patients with EHMs (p < 0.001). Varied EHM sites of patients had different characteristics of primary location site, grade, and histology. Cumulative incidence rates for CSS surpassed that for other causes in patients with 0, 1, 2, ≥ 3 EHMs, and the patients with more numbers of sites of EHMs revealed worse prognosis in CSS (p < 0.001). However, patients with different EHM sites had a minor difference in cumulative incidence rates for CSS (p = 0.106). Finally, a nomogram was constructed to predict the survival probability of patients with EHMs, which is based on the number of sites of EHMs and has been proven an excellent predictive ability. CONCLUSION: The number of sites of EHMs was a significant prognostic factor of CC patients with LM. However, the sites of EHMs showed limited impact on survival. Furthermore, a nomogram based on the number of sites of EHMs was constructed to predict the OS of patients with EHMs accurately. Frontiers Media S.A. 2023-06-06 /pmc/articles/PMC10280983/ /pubmed/37346071 http://dx.doi.org/10.3389/fonc.2023.1172670 Text en Copyright © 2023 Bai, Chen, Zhu, Xuan, Hu, Liu, Li, Lan, Chen, Yan, Li, Yang and Ren https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Bai, Shuheng Chen, Ling Zhu, Guixian Xuan, Wang Hu, Fengyuan Liu, Wanyi Li, Wenyang Lan, Ning Chen, Min Yan, Yanli Li, Rong Yang, Yiping Ren, Juan Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study |
title | Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study |
title_full | Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study |
title_fullStr | Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study |
title_full_unstemmed | Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study |
title_short | Prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study |
title_sort | prognostic value of extrahepatic metastasis on colon cancer with liver metastasis: a retrospective cohort study |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280983/ https://www.ncbi.nlm.nih.gov/pubmed/37346071 http://dx.doi.org/10.3389/fonc.2023.1172670 |
work_keys_str_mv | AT baishuheng prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT chenling prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT zhuguixian prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT xuanwang prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT hufengyuan prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT liuwanyi prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT liwenyang prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT lanning prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT chenmin prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT yanyanli prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT lirong prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT yangyiping prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy AT renjuan prognosticvalueofextrahepaticmetastasisoncoloncancerwithlivermetastasisaretrospectivecohortstudy |